GemPharmatech Co., Ltd. (SHA:688046)
China
· Delayed Price · Currency is CNY 20.66
+0.20 (0.98%)
At close: Apr 29, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 8.47 billion as of April 29, 2026. Its market cap has increased by 40.69% in one year.
Market Cap
8.47B
Enterprise Value
7.62B
Revenue
830.61M
Ranking
n/a
PE Ratio
51.55
Stock Price
20.66
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 8.47B, an increase of 11.68%. That is a compound annual growth rate of 2.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 8.47B | 34.51% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Ausun Pharmaceutical | 8.43B |
| Youcare Pharmaceutical Group | 8.49B |
| Sino Biological,Inc. | 8.53B |
| Daan Gene | 8.10B |
| Bio-Thera Solutions | 8.78B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.86B |
| Shanghai Medicilon | 8.89B |
| Nanjing Vazyme Biotech | 7.84B |